June 17, 2021 | Dyan Bryson, Impetus Digital, Inspired Health Strategies, Natalie Yeadon, Patient Focused Drug Development, adherence, patient advocacy, patient education, patient experience, patient-centric trials, technology, virtual clinical trials
Dyan Bryson from Inspired Health Strategies discusses Patient Focused Drug Development, best practices for designing diverse and patient-centric trials, and how to use technology to improve the patient experience. She also dives into virtual clinical trials and give her tips for building and enhancing patient advocacy, adherence, and education programs.
This content was provided by Impetus Digital
Company Details
Latest Content from Impetus Digital
A French pharmaceutical team contacted Impetus Digital to help them establish a Virtual Steering Committee for patients with HIV/AIDS. They wanted to find a way to directly involve patients in…
Tips on how to optimize congress information-gathering…
Anthony Capone, President of DocGo, shares how his company uses last-mile mobile health services and integrated medical transportation solutions to make healthcare more accessible for everyone, including underserved populations.To find…
The Honourable Tony Clement, Co-chair at Reshoring Canada and former Minister of Health, discusses digital transformation, the importance of onshore manufacturing and supply chain operations in Canada, current pharmaceutical regulatory…
Rishi Nayyar, Co-founder & CEO of PocketHealth, explores how releasing medical imaging records straight to patients can result in data moving more ethically, easily, and securely. He also shares his…
In the latest episode of Impetus Digital’s Fireside Chat series, Natalie Yeadon, Co-Founder and CEO of Impetus Digital talks to Eddie Power, Vice President of North America Medical Affairs, Hospital…
Dr. Jason Cross, Co-founder & Chief Strategy Officer at Rymedi, dives into Connected Health, including how it can be used to expand access to high-quality healthcare, current barriers to its…
Dr. Tom Sawyer, CFO at Cognetivity Neurosciences, discusses the benefits of AI-driven dementia detection technology for patients, health care providers, and clinical research.To find out more about Impetus: https://www.meetwithimpetus.comImpetus Digital…
Our client wanted to better understand the needs, preferences, and treatment gaps among adult patients with a rare genetic disease…
Dr. Shahar Keinan, Co-founder & CEO of POLARIS Quantum Biotech, explores quantum computing and AI for drug discovery, the Quantum Molecular Design process, and how POLARISqb is working to improve…
